RA Capital Management’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
Other funds holding INO
RA Capital Management's INO Position: Q3 2026 in Review
RA Capital Management opened a new position in Inovio Pharmaceuticals (INO) in Q3 2026: 7,220,384 shares worth $8.81M. The stake represents 0.09% of the portfolio and ranks #79 among its holdings.
110 funds tracked by Wall St. Rank hold INO as of Q3 2026.
- RA Capital Management held 7,220,384 shares of Inovio Pharmaceuticals worth $8.81M as of Q3 2026.
- Inovio Pharmaceuticals was a new RA Capital Management position in Q3 2026.
- Inovio Pharmaceuticals made up 0.09% of RA Capital Management's portfolio in Q3 2026, its #79 holding.
- 110 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q3 2026.
Based on RA Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.